You are at right place to check all the details regarding Valiant Laboratories IPO. The dates for Valiant Laboratories IPO is anounced. The IPO will open on September 27 and will close on October 3. The IPO price band is fixed at ₹133 to ₹140 Per Share. The company aims to to raise around ₹152 crores via this IPO. You can find complete information about Valiant Laboratories IPO in this post including its strenght and risks, peer comparison and financial performance.
.
About Valiant Laboratories :
Valiant Laboratories are an Active Pharmaceutical Ingredient (“API”) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. Bulk drugs/Active Pharmaceutical Ingredients (API) serve as raw materials for manufacturing finished dosage forms or formulations. Paracetamol , is one of the most commonly taken analgesic worldwide and is recommended as the first-line therapy in pain conditions by the World Health Organization (WHO). Paracetamol has several applications such as usage in treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold and fever. Company manufactures Paracetamol in variousgrades such as IP/BP/EP/USP, as per the pharmacopeia requirements of our customers.
Valiant Laboratories History:
Company was originally formed in year 1980 as a partnership firm under the Indian Partnership Act, 1932 under the name and style of “M/s. Bharat Chemicals” and gradually, commenced manufacturing of Paracetamol by late 1982. In August 2021, their partnership firm was converted into a public limited company registered under the Companies Act.
Objects of the Issue
- Investment in thier wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (“VASPL”) for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for speciality chemicals at Saykha Industrial Area, Bharuch, Bharuch, Gujarat (“Proposed Facility”).
- Investment in VASPL for funding its working capital requirements.
- General corporate purposes
Valiant Laboratories IPO Date & Price Band Details
IPO Open: | September 27, 2023 |
IPO Close: | October 3, 2023 |
IPO Size: | Approx ₹152 Crores |
Fresh Issue: | Approx 11,556,000 shares |
Face Value: | ₹10 Per Equity Share |
IPO Price Band: | ₹133 to ₹140 Per Share |
IPO Listing on: | BSE & NSE |
Retail Quota: | 35% |
QIB Quota: | 50% |
NII Quota: | 15% |
Discount: | N/A |
DRHP Draft Prospectus: | Click Here |
RHP Draft Prospectus: | Click Here |
Valiant Laboratories IPO Market Lot
The Valiant Laboratories IPO minimum market lot is 105 shares with ₹14,700 application amount. The retail investors can apply up-to 13 lots with 1365 shares or ₹1,91,100 amount.
Category | Lot Size | Shares | Required Amount |
Retail Minimum | 1 | 105 | ₹14,700 |
Retail Maximum | 13 | 1365 | ₹191,100 |
S-HNI Minimum | 14 | 1470 | ₹205,800 |
B-HNI Minimum | 69 | 7245 | ₹10,14,300 |
Valiant Laboratories IPO Allotment & Listing Dates
The Valiant Laboratories IPO date is September 27 and the close date is October 3. The Valiant Laboratories IPO allotment will be finalized on October 6 and the IPO listing on October 11.
Anchor Investors Allotment: | September 26, 2023 |
IPO Open Date: | September 27, 2023 |
IPO Close Date: | October 3, 2023 |
Basis of Allotment: | October 6, 2023 |
Refunds: | October 9, 2023 |
Credit to Demat Account: | October 10, 2023 |
IPO Listing Date: | October 11, 2023 |
Valiant Laboratories Company Financial Report
Year | Revenue (Cr) | Expense (Cr) | PAT (Cr) |
2021 | ₹183.78 | ₹136.75 | ₹30.59 |
2022 | ₹293.47 | ₹251.76 | ₹27.49 |
2023 | ₹338.77 | ₹300.63 | ₹28.99 |
Valiant Laboratories IPO Valuation
Below is the financial details of Valiant Laboratories for the year FY2023.
Earning Per Share (EPS): | ₹8.91 per Equity Share |
Price/Earning P/E Ratio: | N/A |
Return on Net Worth (RoNW): | 28.86% |
Net Asset Value (NAV): | ₹30.86 per Equity Share |
Company Promoters:
- Shantilal Shivji Vora
- Dhanvallabh Ventures LLP
Valiant Laboratories Limited: Strengths
- Leading player in the pharmaceutical ingredient manufacturing industry in India.
- Valiant has a long track record of profitability and growth.
- Proceeds from the funding will be used for laboratory growth.
- Valiant has a diversified product portfolio and a strong customer base.
- Valiant Laboratories Limited has shifted its focus and now mostly gets its raw materials from Valiant Organics Limited. This move has not only strengthened their teamwork but also made things more cost-effective and sped up deliveries.
Valiant Laboratories Limited: Risks
- Valiant has high competition in the pharmaceutical ingredient manufacturing industry.
- The business cycle of the Laboratories is dependent on the overall economic conditions.
- Foreign exchange fluctuations and changes in government regulations impact the business.
- The company is dependent on a few customers who contribute a major part of its revenue.
Competitors Comparison:
Below table captures the peer companies operating in the same industry and company’s comparison with its competitors in last financial year.
Valiant Laboratories | Ganules India | Jagsonpal Pharma | Alkyl Amines | Laxmi Organics | |
Revenue (Cr) | 338.772 | 1,198.88 | 58.01 | 414.51 | 737.02 |
PAT (Cr) | 28.998 | 119.6 | 5.6 | 48.64 | 24.27 |
Market Capital | NA | 8,141.11 | 1,085.12 | 12,097.90 | 7,647.29 |
Valiant Laboratories IPO Registrar
Link Intime India Private Limited
Phone: +91 8108114949
Email: valiantlaboratories.ipo@linkintime.co.in
Website: https://linkintime.co.in/
Valiant Laboratories IPO Lead Managers
- Unistone Capital Private Limited
Valiant Laboratories IPO Allotment Status Check
Allotment status of Valiant Laboratories IPO can be checked on Linkintime website : Click here
Company Address of Valiant Laboratories:
Valiant Laboratories Limited
104, Udyog Kshetra, Mulund Goregaon Link Road,
Mulund West,
Mumbai -400080, Maharashtra
Phone: +91 2249712001
Email: complianceofficer@valiantlabs.in
Website: www.valiantlabs.in
Valiant Laboratories IPO FAQs
When Valiant Laboratories IPO will open and close?
The IPO is to open on September 27, 2023 for QIB, NII, and Retail Investors and closes on October 03,2023
What is Valiant Laboratories IPO Investors Portion?
The investors’ portion for QIB is 50%, NII is 15%, and Retail is 35%.
What is the Valiant Laboratories IPO Allotment Date?
Valiant Laboratories IPO allotment date is October 6, 2023.
What is the Valiant Laboratories IPO Listing Date?
Valiant Laboratories IPO listing date is October 11, 2023. The IPO is to list on BSE and NSE.
How to Apply the Valiant Laboratories IPO through Zerodha?
You can apply to this IPO through Zerodha by logging in to Console in Zerodha Website. Go to Portfolio and Click on IPO. You will see the IPO Name “Valiant Laboratories”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App like PhonePe or GooglePay etc to Approve the mandate. If you still dont have Demat account with Zerodha you can open it using this link, Open Demat Account with Zerodha.